A Stock that Will Beat the 40% Gains in the Pharma Sector Hands Down

May 6, 2020

When I think of it now, it seems quite eerie.

On the 31st of December 2019, I recorded a video, at the Equitymaster office. At that time, somewhere in Wuhan, China, one of the first cases of Coronavirus was getting confirmed.

My video - The One Sector Set for Big Rebound in 2020 and Beyond - was on the big potential of the Indian pharma sector in 2020.

But like everyone else, I had not even heard of coronavirus until then.

Indian pharma companies already had a terrible few years thanks to their USFDA woes. Earnings had been very volatile. Valuations were at rock bottom. So, my optimism about the sector was not founded on the basis of any potential global pandemic.

Coronavirus or not, I knew a few pharma companies in India were all set to rebound.

But coronavirus or Covid-19, proved India's importance to the world for low cost generic drug production. Billions of dollars are now being poured into vaccine research.

But the job of making billions of vaccine doses available will still rest with low cost vaccine manufacturers. Some of them will certainly be from Indian pharma.

It is therefore of little wonder that Indian pharma stocks went up 30% to 70% in the past two months.

The BSE Healthcare index gained 40% even as every other index bled.

But you would be wrong to assume that drug manufacturers will be the biggest gainers in a post Covid-19 world.

Rather, the technology that will help diagnose patients and prescribe drugs, world over, will see exponential growth.

And it answers to the name of Telemedicine.

--- Advertisement ---
New FREE Guide on Big Opportunity in Defence

Tanushree Banerjee, the co-head of research, recently released er latest guide:

The Explosive Rs.4 Lakh Crore Opportunity: How to Tap into India's Surging Defence Sector for Potentially Huge Profits

And she has agreed to make it available for free for a limited time.

If you've not claimed your free copy, then do so now. It might not remain free for long. One more thing...

Tanushree has also discovered one stock from defence sector... which she believes has the potential to multiply invested money 10-times in the long run.

She will reveal more details about this stock at her upcoming online special event.

Click Here to Download the Guide & Block Your Seat Now. It's Free.

Telemedicine basically means offering virtual healthcare when the doctor and patient are at remote locations.

The technology equips diagnostic tools like BP apparatus, ECG, glucometer etc with artificial intelligence. It helps doctors diagnose patients and prescribe medicines.

Traditionally, telemedicine has been associated with providing better healthcare access to under-served communities, rural populations, and low-income groups.

But Covid19 has made it a new normal for urban areas too.

One of the niche technology companies I've been tracking for the past five years, has been innovating in the telemedicine space for a while.

--- Advertisement ---
Listen to Some of The Biggest Investment Minds of This Country... Right from The Safety and Comfort of Your Own Home...

Interested in growing - and most importantly, protecting - your wealth in 2021 and beyond?

Then you'll love to Register For The Equitymaster Annual Conference 2021.

Where top investment gurus will reveal their most lucrative investing and wealth-protection strategies for the coming years.

And since This Conference Is Fully Virtual - you can listen to them right from the comfort and safety of your own home...

So what are you waiting for?

Register for the Conference Right Now

It has published research papers on integrating medical science with augmented and virtual reality, 3-D printing, robotics, and advanced IoT and AI capabilities.

In the last few quarters, the company has been investing heavily into this vertical.

I am confident the business is currently at an inflection point. Especially, for its agility in capturing the opportunities in the post Covid-19 world.

I have explained my rationale in detail, in my special report.

Looking at the potential upside in the stock, over a period of five to ten years, I believe investors could become a One Stock Crorepati.

Warm regards,

Tanushree Banerjee
Tanushree Banerjee
Editor, StockSelect
Equitymaster Agora Research Private Limited (Research Analyst)

PS: Find out more about this exciting stock here.

Recent Articles

Is this Sector the Best Contrarian Bet Right Now? November 23, 2020
The risk reward ratio in this beaten down sector may have finally turned for the better.
I Trust Tanushree to Pick India's Best Defence Stock for You November 20, 2020
The set up that made Jim Rogers famous is now up for grabs in India.
Lesson for Investors from the Lakshmi Vilas Bank Fiasco November 19, 2020
Be it investing in fixed deposits or stocks, investors should always focus on protecting their capital first.
Build a Robust Portfolio in these Fragile Times November 18, 2020
With all the uncertainty it has brought, Covid has also offered a lens to the assess the survival quotient of individual businesses.

Equitymaster requests your view! Post a comment on "A Stock that Will Beat the 40% Gains in the Pharma Sector Hands Down". Click here!